The treatment of lupus pernio results of 116 treatment courses in 54 patients

Chest

Volumn 135, Issue 2, 2009, Pages 468-476

  Stagaki, Eleni ^a   Mountford, William K ^b   Lackland, Daniel T ^b   Judson, Marc A ^c  

^a SISMANOGLIO HOSPITAL   (Greece)

^b and Epidemiology ^*  (China)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Infliximab; Lupus pernio; Skin; Systemic corticosteroids; Therapy

Indexed keywords

AZATHIOPRINE; CHLOROQUINE; CORTICOSTEROID; HYDROXYCHLOROQUINE; INFLIXIMAB; METHOTREXATE; MINOCYCLINE; PENTOXIFYLLINE; PREDNISONE; RETINOIC ACID; TACROLIMUS; THALIDOMIDE;

ADULT; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CONVALESCENCE; DATA BASE; FACE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OUTPATIENT DEPARTMENT; PHOTOGRAPHY; PRIORITY JOURNAL; QUALITY OF LIFE; SARCOIDOSIS; SECONDARY ANALYSIS; STATISTICAL SIGNIFICANCE; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 60249097515     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.08-1347     Document Type: Article

References (33)

1. Marchell RM, Judson MA. Chronic cutaneous lesions of sarcoidosis. Clin Dermatol 2007; 25:295-302
2. Spiteri MA, Matthey F, Gordon T, et al. Lupus pernio: a clinico-radiological study of thirty-five cases. Br J Dermatol 1985; 112:315-322
3. Neville E, Walker AN, James DG. Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients. Quart J Med 1983; 208:525-533
4. Yanardaq H, Pamuk ON, Karfayel T. Cutaneous involvement in sarcoidosis: analysis of the features in 170 patients. Respir Med 2003; 97:978-982
5. Graefe T, Konrad H, Barta U, et al. Successful ultraviolet A1 treatment of cutaneous sarcoidosis. Br J Dermatol 2001; 145:354-355
6. Frizzell B, Stith M, Jenrette J. Management of treatment-resistant cutaneous sarcoidosis with radiation. Am J Clin Oncol 2002; 25:573-575
7. Nowack U, Gambichler T, Hanefeld C, et al. Successful treatment of recalcitrant cutaneous sarcoidosis with fumaric acid esters. BMC Dermatol 2002; 2:15
8. Carlesimo M, Giustini S, Rossi A, et al. Treatment of cutaneous and pulmonary sarcoidosis with thalidomide. J Am Acad Dermatol 1995; 32:866-869
9. Katoh N, Mihara H, Yasuno H. Cutaneous sarcoidosis successfully treated with topical tacrolimus. Br J Dermatol 2002; 147:154-156
10. Khanna D, Liebling MR, Louie JS. Etanercept ameliorates sarcoidosis arthritis and skin disease. J Rheumatol 2003; 30:1864-1867
11. Yamada H, Ide A, Sugiura M, et al. Treatment of cutaneous sarcoidosis with tranilast. J Dermatol 1995; 22:149-152
12. Bregnhoej A, Jemec GB. Low-dose allopurinol in the treatment of cutaneous sarcoidosis: response in four of seven patients. J Dermatol Treat 2005; 16:125-127
13. Mosam A, Morar N. Recalcitrant cutaneous sarcoidosis: an evidence-based sequential approach. J Dermatol Treat 2004; 15:353-359
14. Bachelez H, Senet P, Cadranel J, et al. The use of tetracyclines for the treatment of sarcoidosis. Arch Dermatol 2001; 137:69-73
15. Nguyen YT, Dupuy A, Cordoliani F, et al. Treatment of cutaneous sarcoidosis with thalidomide. J Am Acad Dermatol 2004; 50:235-241
16. Doty JD, Mazur JE, Judson MA. Treatment of sarcoidosis with infliximab. Chest 2005; 127:1064-1071
17. Baughman RP, Judson MA, Teirstein AS, et al. Thalidomide for chronic sarcoidosis. Chest 2002; 122:227-232
18. Judson MA, Baughman RP, Teirstein AS, et al. Defining organ involvement in sarcoidosis: the ACCESS proposed instrument; ACCESS Research Group, A Case Control Etiologic Study of Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16:75-86
19. Baughman RP, Drent M, Kavuru M, et al. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 2006; 174:795-802
20. Judson MA, Baughman RP, Costabel U, et al. Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomized trial. Eur Respir J 2008; 31:1189-1196
21. Lower EE, Baughman RP. Prolonged use ofmethotrexate for sarcoidosis. Arch Intern Med 1995; 155:846-851
22. Webster GF, Razsi LK, Sanchez M, et al. Weekly low-dose methotrexate therapy for cutaneous sarcoidosis. J Am Acad Dermatol 1991; 24:451-454
23. Muller-Quernheim J, Kienast K, Held M, et al. Treatment of chronic sarcoidosis with azathioprine/prednisolone regimen. Eur Respir J 1999; 14:117-1122
24. Zie J, Horowitz D, Arzubiaga C, et al. Treatment of cutaneous sarcoidosis with chloroquine: review of the literature. Arch Dermatol 1991; 127:1034-1040
25. Jones E, Cagen JP. Hydroxychloroquine is effective therapy for control of cutaneous sarcoidal granulomas. Am Acad Dermatol 1990; 23:487-490
26. Doty JD, Mazur JE, Judson MA. Treatment of sarcoidosis with infliximab. Chest 2005; 127:1064-1071
27. Nowack U, Gambichler T, Hanefeld C, et al. Successful treatment of recalcitrant cutaneous sarcoidosis with fumaric acid esters. BMC Dermatol 2002; 2:15
28. Bachelez H, Senet P, Cadranel J, et al. The use of tetracyclines for the treatment of sarcoidosis. Arch Dermatol 2001; 137:69-73
29. Kouba DJ, Mimouni D, Rencic A, et al. Mycophenolate mofetil may serve as a steroid-sparing agent for sarcoidosis. Br J Dermatol 2003; 148:147-148
30. Bregnhoej A, Jemec GBE. Low-dose allopurinol in the treatment of cutaneous sarcoidosis: response in four of seven patients. J Dermatol Treat 2005; 16:125-127
31. Yamada H, Ide A, Sugiura M, et al. Treatment of cutaneous sarcoidosis with tranilast. J Dermatol 1995; 22:149-152
32. Katoh N, Mihara H, Yasuno H. Cutaneous sarcoidosis successfully treated with topical tacrolimus. Br J Dermatol 2002; 147:154-156
33. Baughman RP, Judson MA, Teirstein A, et al. Chronic facial sarcoidosis including lupus pernio: clinical description and proposed scoring systems. Am J Clin Dermatol 2008; 9:155-161